PEPTICHEMIO, VINCRISTINE AND PREDNISONE VERSUS MELPHALAN AND PREDNISONE AS INDUCTION THERAPY IN MULTIPLE-MYELOMA

被引：14
|
作者：
RICCARDI, A
MERLINI, G
MONTECUCCO, C
DANOVA, M
UCCI, G
CASSANO, E
ASCARI, E
机构：
[1] CARATTERE SCI POLICLIN S MATTEO, IST RICOVERO & CURA, I-27100 PAVIA, ITALY
[2] UNIV PAVIA, DIPARTIMENTO MED INTERNA & TERAPIA MED, I-27100 PAVIA, ITALY
来源：
EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY | 1986年 / 22卷 / 07期
关键词：
D O I：
10.1016/0277-5379(86)90364-0
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：787 / 791
页数：5
相关论文
共 50 条
  • [41] TREATMENT OF MULTIPLE-MYELOMA WITH MELPHALAN AND PREDNISONE GIVEN IN INTERMITTENT COURSES - REPORT OF 22 CASES
    COLCOMBET, P
    JOLY, J
    LAURENT, J
    MEUNIER, P
    VIGNON, G
    [J]. LYON MEDICAL, 1977, 237 (03): : 193 - 198
  • [42] Prospective randomized trial of melphalan and prednisone versus vincristine, carmustine, melphalan, cyclophosphamide, and prednisone in the treatment of primary systemic amyloidosis
    Gertz, MA
    Lacy, MQ
    Lust, JA
    Greipp, PR
    Witzig, TE
    Kyle, RA
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (01) : 262 - 267
  • [43] CONTRIBUTION OF PREDNISONE TO THE EFFECTIVENESS OF HEXAMETHYLMELAMINE IN MULTIPLE-MYELOMA
    OKEN, MM
    LENHARD, RE
    TSIATIS, AA
    GLICK, JH
    SILVERSTEIN, MN
    [J]. CANCER TREATMENT REPORTS, 1987, 71 (09): : 807 - 811
  • [44] HEXAMETHYLMELAMINE AND PREDNISONE IN THE TREATMENT OF REFRACTORY MULTIPLE-MYELOMA
    COHEN, HJ
    BARTOLUCCI, AA
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1982, 5 (01): : 21 - 27
  • [45] Erratum: Melphalan and prednisone versus melphalan, prednisone and thalidomide for elderly and/or transplant-ineligible patients with multiple myeloma: a meta-analysis
    P Kapoor
    S V Rajkumar
    A Dispenzieri
    M A Gertz
    M Q Lacy
    D Dingli
    J R Mikhael
    V Roy
    R A Kyle
    P R Greipp
    S Kumar
    S J Mandrekar
    [J]. Leukemia, 2011, 25 : 1523 - 1524
  • [46] A prospective randomized trial of melphalan and prednisone versus vincristine, carmustine, melphalan, cyclophosphamide, and prednisone in the treatment of primary systemic amyloidosis
    Gertz, MA
    Lacy, MQ
    Lust, JA
    Greipp, PR
    Witzig, TE
    Kyle, RA
    [J]. AMYLOID AND AMYLOIDOSIS 1998, 1999, : 96 - 98
  • [47] CISPLATIN, BCNU, CYCLOPHOSPHAMIDE, AND PREDNISONE IN MULTIPLE-MYELOMA
    BROUN, GO
    PETRUSKA, PJ
    HIRAMOTO, RN
    COHEN, HJ
    [J]. CANCER TREATMENT REPORTS, 1982, 66 (02): : 237 - 242
  • [48] Comparison of melphalan and prednisone with vincristine, carmustine, melphalan, cyclophosphamide, and prednisone in the treatment of multiple myeloma - Results of Eastern Cooperative Oncology Group Study E2479
    Oken, MM
    Harrington, DP
    Abramson, N
    Kyle, RA
    Knospe, W
    Glick, JH
    [J]. CANCER, 1997, 79 (08) : 1561 - 1567
  • [49] EVALUATION OF VINCRISTINE AS AN ADJUNCT TO INTERMITTENT MELPHALAN AND PREDNISONE THERAPY IN MYELOMATOSIS
    MACLENNAN, ICM
    [J]. BRITISH JOURNAL OF CANCER, 1985, 52 (03) : 422 - 422
  • [50] MELPHALAN AND PREDNISONE MANAGEMENT OF MYELOMA
    不详
    [J]. SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT, 1969, 99 (41) : 1490 - &
12345